Breast cancer management and outcome according to surgeon's affiliation: a population-based comparison adjusted for patient's selection bias.

BACKGROUND Studies have reported that breast cancer (BC) units could increase the quality of care but none has evaluated the efficacy of alternative options such as private BC networks, which is our study objective. PATIENTS AND METHODS We included all 1404 BC patients operated in the public unit or the private network and recorded at the Geneva Cancer Registry between 2000 and 2005. We compared quality indicators of care between the public BC unit and the private BC network by logistic regression and evaluated the effect of surgeon's affiliation on BC-specific mortality by the Cox model adjusting for the propensity score. RESULTS Both the groups had high care quality scores. For invasive cancer, histological assessment before surgery and axillary lymph node dissection when indicated were less frequent in the public sector (adjusted odds ratio (OR): 0.4, 95% confidence interval (CI) 0.3-0.7, and OR: 0.4, 95% CI 0.2-0.8, respectively), while radiation therapy after breast-conserving surgery was more frequent (OR: 2.5, 95% CI 1.4-4.8). Surgeon affiliation had no substantial effect on BC-specific mortality (adjusted hazard ratio (HR): 0.8, 95% CI 0.5-1.4). CONCLUSIONS This study suggests that private BC networks could be an alternative to public BC units with both structures presenting high quality indicators of BC care and similar BC-specific mortality.

[1]  Katherine E Henson,et al.  Risk of Suicide After Cancer Diagnosis in England , 2018, JAMA psychiatry.

[2]  D. Ghersi,et al.  Post-operative radiotherapy for ductal carcinoma in situ of the breast. , 2013, The Cochrane database of systematic reviews.

[3]  P. Lønning,et al.  Hospital volume and prognosis among Norwegian breast cancer patients enrolled in adjuvant trials , 2011, Acta oncologica.

[4]  W. Dooley,et al.  Mechanisms of Improved Outcomes for Breast Cancer between Surgical Oncologists and General Surgeons , 2011, Annals of Surgical Oncology.

[5]  Marvin Zelen,et al.  Effect of screening mammography on breast-cancer mortality in Norway. , 2010, The New England journal of medicine.

[6]  L Biganzoli,et al.  Quality indicators in breast cancer care. , 2010, European journal of cancer.

[7]  Anna R. Gagliardi,et al.  Examining the potential relationship between multidisciplinary cancer care and patient survival: An international literature review , 2010, Journal of surgical oncology.

[8]  G. Vlastos,et al.  Geographic variation in breast cancer care in Switzerland. , 2010, Cancer epidemiology.

[9]  Arnold Knijn,et al.  EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. , 2009, European journal of cancer.

[10]  M. Mottolese,et al.  A Phase II Trial of Docetaxel and Vinorelbine in Patients with Advanced Breast Cancer Previously Treated with Anthracyclines , 2008, Oncology.

[11]  L. Koniaris,et al.  Are Many Community Hospitals Undertreating Breast Cancer?: Lessons From 24,834 Patients , 2008, Annals of surgery.

[12]  R. Salamon,et al.  Breast cancer surgery: do all patients want to go to high-volume hospitals? , 2008, Surgery.

[13]  A. Chan,et al.  A review of the use of trastuzumab (Herceptin) plus vinorelbine in metastatic breast cancer. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  Mark A Helvie,et al.  Changes in surgical management resulting from case review at a breast cancer multidisciplinary tumor board , 2006, Cancer.

[15]  Nehmat Houssami,et al.  Breast cancer: multidisciplinary care and clinical outcomes. , 2006, European journal of cancer.

[16]  H. Verkooijen,et al.  Social class is an important and independent prognostic factor of breast cancer mortality , 2006, International journal of cancer.

[17]  A. Bordoni,et al.  Variation in survival after diagnosis of breast cancer in Switzerland. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[18]  R. Pietrobon,et al.  High Hospital Volume Is Associated with Better Outcomes for Breast Cancer Surgery: Analysis of 233,247 Patients , 2005, World Journal of Surgery.

[19]  G. Vlastos,et al.  Undertreatment strongly decreases prognosis of breast cancer in elderly women. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  Y. Tokuda,et al.  Combination of trastuzumab and vinorelbine in metastatic breast cancer. , 2003, Japanese journal of clinical oncology.

[21]  B. Stewart,et al.  World Cancer Report , 2003 .

[22]  Eusoma The requirements of a specialist breast unit. , 2000, European journal of cancer.

[23]  M. Sliwkowski,et al.  Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers , 1999, Oncogene.

[24]  Donald Rubin,et al.  Estimating Causal Effects from Large Data Sets Using Propensity Scores , 1997, Annals of Internal Medicine.

[25]  C. Gillis,et al.  Survival outcome of care by specialist surgeons in breast cancer: a study of 3786 patients in the west of Scotland , 1996, BMJ.

[26]  S. Feig Effect of Screening Mammography on Breast-Cancer Mortality in Norway , 2011 .

[27]  D. Ghersi,et al.  Post-operative radiotherapy for ductal carcinoma in situ of the breast. , 2009, The Cochrane database of systematic reviews.

[28]  Leslie H. Sobin,et al.  TNM Classification of Malignant Tumours, 7th Edition , 2009 .

[29]  Wei Ye,et al.  Breast Cancer: Do Specialists Make a Difference? , 2003, Annals of Surgical Oncology.

[30]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.